-
Bajaj Finance
1,151.20 1,151.20(%) -
Torrent Pharma.
5,139.30 5,139.30(%) -
Netweb Technol.
4,597.95 5,241.65(%) -
TVS Motor Co.
4,320.00 4,320.00(%) -
Rossell Techsys
979.95 1,111.00(%) -
Indo-MIM
815.90 815.90(%) -
Kaynes Tech
3,860.55 7,705.00(%) -
Hero Motocorp
5,397.80 6,390.00(%) -
63 Moons Tech.
949.65 1,029.35(%) -
Adani Ports
1,707.00 1,891.80(%) -
Shadowfax Technologies
253.35 253.35(%) -
Kalyan Jewellers
610.15 327.15(%) -
M & M
3,456.00 3,840.00(%) -
Tata Motors
440.40 508.95(%) -
HFCL
194.30 229.40(%) -
Hyundai Motor I
2,208.90 2,889.65(%) -
Swiggy
280.00 235.85(%) -
TBO Tek
1,565.80 1,764.00(%) -
Reliance Industries
1,309.30 1,611.20(%) -
Eicher Motors
7,795.00 5,390.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Aarti Pharmalabs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Aarti Group
- BSE Code : 75909.0
- ISIN : INE0LRU01027
-
Today’s Low
650.80 -
Today’s High
674.00
-
Open
661.35 -
Perv Close
674.30 -
52W Low
585.00 -
52W High
946.10
Key Indicators
-
P/E(TTM)
33.98
-
Mar.Cap (₹Cr.)
6,049.70
-
Div & Yield %
0.52
-
Book Value(₹)
218.61
-
Debt-Equity Ratio
-1.06
-
AGM Date
31-Jul-2026
-
EPS
19.66
-
P/E Ratio
33.98
Financials Ratios
-
Debt-Equity Ratio
0.15
-
Mar.Cap (₹Cr.)
6,049.70
-
RONW (%)
13.08
-
ROCE (%)
16.60
Score Board
-
Equity (₹ in Cr.)
45.34
-
BV (₹)
218.60
-
Sales( ₹ in Cr.)
1,797.55
-
NP (in Cr.)
178.30
-
NP Var(%)
-31.0
-
Div%
70.0
-
CPS (₹)
31.20
-
EPS (₹)
19.70
-
Traded Value (₹ in Lakhs)
6,056.96
-
52 Week High
946.10
-
52 Week Low
585.00
-
Price BSE
668.0
-
Price NSE
667.00
-
Market Capital( in Cr.)
6,056.96
-
P/C Ratio
21.40
-
P/E Ratio
34.00
-
Price Vs.BV
19.70
-
28-Jul-2026( 02:40)
Corporate News - Aarti... - Aarti Pharmalabs will hold a...
-
25-Jun-2026( 01:30)
Corporate News - Aarti... - Aarti Pharmalabs has allotted...
-
26-May-2026( 10:53)
Corporate News - Board... - Aarti Pharmalabs announced th...
-
26-May-2026( 07:38)
Results - Announcements - Aarti... - Net profit of Aarti Pharmalabs...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 1,771.35 | 1,502.13 | 1,511.25 | 941.02 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,771.35 | 1,502.13 | 1,511.25 | 941.02 | 0.00 | 0.00 |
| Other Income | 14.49 | 11.01 | 1.28 | 2.51 | 0.00 | 0.00 |
| Stock Adjustments | -47.85 | 23.36 | 91.22 | 32.54 | 0.00 | 0.00 |
| Total Income | 1,737.99 | 1,536.50 | 1,603.75 | 976.07 | 0.00 | 0.00 |
| EXPENDITURE : | ||||||
| Raw Materials | 831.41 | 775.33 | 909.15 | 484.20 | 0.00 | 0.00 |
| Power and Fuel Cost | 80.19 | 82.92 | 74.22 | 43.43 | 0.00 | 0.00 |
| Employee Cost | 139.82 | 120.15 | 113.92 | 79.98 | 0.00 | 0.00 |
| Other Manufacturing Expenses | 118.83 | 109.26 | 91.11 | 164.69 | 0.00 | 0.00 |
| Selling and Administration Expenses | 101.22 | 66.55 | 82.93 | 21.46 | 0.00 | 0.02 |
| Miscellaneous Expenses | 25.49 | 25.13 | 22.80 | 0.01 | 0.00 | 0.00 |
| Employee Benefit Expenses | 139.82 | 120.15 | 113.92 | 79.98 | 0.00 | 0.00 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 1,296.95 | 1,179.33 | 1,294.14 | 793.78 | 0.00 | 0.02 |
| Operating Profit | 441.03 | 357.16 | 309.62 | 182.30 | 0.00 | -0.02 |
| Interest | 25.63 | 16.63 | 20.49 | 11.34 | 0.00 | 0.00 |
| Gross Profit | 415.40 | 340.53 | 289.13 | 170.96 | 0.00 | -0.02 |
| Depreciation | 79.06 | 66.01 | 55.77 | 37.23 | 0.00 | 0.00 |
| Profit Before Tax | 336.34 | 274.52 | 233.36 | 133.73 | 0.00 | -0.02 |
| Current Tax | 56.71 | 46.06 | 52.13 | 22.50 | 0.00 | 0.00 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 22.28 | 27.82 | 9.50 | 4.50 | 0.00 | 0.00 |
| Reported Net Profit | 257.35 | 200.65 | 171.73 | 106.73 | 0.00 | -0.02 |
| Extraordinary Items | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
| Adjusted Net Profit | 257.35 | 200.65 | 171.73 | 106.70 | 0.00 | -0.02 |
| Adjustment below Net Profit | -1.42 | 0.00 | 0.00 | 599.24 | 0.00 | 0.00 |
| P & L Balance brought forward | 1,042.07 | 859.55 | 705.95 | -0.02 | -0.02 | 0.00 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 31.72 | 18.13 | 18.13 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 1,266.28 | 1,042.07 | 859.55 | 705.95 | -0.02 | -0.02 |
| Dividend | 0.00 | 0.00 | 18.13 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 100.00 | 60.00 | 40.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 5.00 | 3.00 | 2.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 28.39 | 22.14 | 18.95 | 4,269.05 | -0.18 | -0.75 |
| Earnings Per Share(Adj)-Unit Curr | 28.39 | 22.14 | 18.95 | - | - | - |
| Book Value | 203.44 | 178.92 | 158.74 | 49,558.52 | 9.07 | 9.25 |
| Book Value(Adj)-Unit Curr | 203.44 | 178.92 | 158.74 | - | - | - |
